arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2012.09627econ.EM
收藏

美国FDA药物批准是持久和多环的:对经济周期,创新动态和国家政策的见解

United States FDA drug approvals are persistent and polycyclic: Insights into economic cycles, innovation dynamics, and national policy

Iraj Daizadeh

摘要:

阐明外部影响(如经济或政策)的变化对美国药物批准率的影响具有挑战性。在这里,提出了一种新的方法,被称为时序赫斯特指数(CHE),它假设的变化,在长期记忆中潜伏在动态的时间序列数据可能会暂时与这种影响的变化。使用FDA药物评价和研究中心(CDER)从1939年到2019年批准的月度数字作为数据源,证明CHE具有由8年划分的明显的S形结构(1939-1947)停滞期,27年(1947-1974)涌现期(时变期)和45年(1974-2019)饱和期。此外,在最近45年的CHE饱和期(17年、8年和4年)中确定了主要周期性(通过小波分析解决);因此,美国药物批准一直遵循具有Kitchin-like爆发的Juan-Kuznet中期周期。如所讨论的,这项工作表明,(1)外在因素的变化(例如,经济和/或政策来源)可能导致自1974年以来美国药物批准的持续增长,(2)CHE可能是探索对时间序列数据影响的有价值的方法,以及(3)存在与创新相关的经济周期(通过美国药物批准的代理指标观察)。

英文摘要:

It is challenging to elucidate the effects of changes in external influences (such as economic or policy) on the rate of US drug approvals. Here, a novel approach, termed the Chronological Hurst Exponent (CHE), is proposed, which hypothesizes that changes in the long-range memory latent within the dynamics of time series data may be temporally associated with changes in such influences. Using the monthly number the FDA Center for Drug Evaluation and Research (CDER) approvals from 1939 to 2019 as the data source, it is demonstrated that the CHE has a distinct S-shaped structure demarcated by an 8-year (1939-1947) Stagnation Period, a 27-year (1947-1974) Emergent (time-varying Period, and a 45-year (1974-2019) Saturation Period. Further, dominant periodicities (resolved via wavelet analyses) are identified during the most recent 45-year CHE Saturation Period at 17, 8 and 4 years; thus, US drug approvals have been following a Juglar-Kuznet mid-term cycle with Kitchin-like bursts. As discussed, this work suggests that (1) changes in extrinsic factors (e.g., of economic and/or policy origin ) during the Emergent Period may have led to persistent growth in US drug approvals enjoyed since 1974, (2) the CHE may be a valued method to explore influences on time series data, and (3) innovation-related economic cycles exist (as viewed via the proxy metric of US drug approvals).

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑